Back
Foghorn Therapeutics Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
50
FHTX
Foghorn Therapeutics
Last Price:
7.60
Seasonality Move:
18.5%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FHTX is experiencing slight selling pressure.
Foghorn Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.93 | Sell |
| 20-day SMA: | 8.33 | Sell |
| 50-day SMA: | 8.52 | Sell |
| 200-day SMA: | 6.74 | Buy |
| 8-day EMA: | 8.66 | Sell |
| 20-day EMA: | 8.5 | Sell |
| 50-day EMA: | 8.2 | Sell |
| 200-day EMA: | 7.08 | Buy |
Foghorn Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 44.69 | Sell |
| Chaikin Money Flow: | -16480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.57 - 8.85) | Sell |
| Bollinger Bands (100): | (6.08 - 8.88) | Buy |
Foghorn Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Foghorn Therapeutics Stock
Is Foghorn Therapeutics Stock a Buy?
- Foghorn Therapeutics share price is 8.01 while FHTX 8-day simple moving average is 8.93, which is a Sell signal.
- The stock price of FHTX is 8.01 while Foghorn Therapeutics 20-day SMA is 8.33, which makes it a Sell.
- Foghorn Therapeutics 50-day simple moving average is 8.52 while FHTX share price is 8.01, making it a Sell technically.
- FHTX stock price is 8.01 and Foghorn Therapeutics 200-day simple moving average is 6.74, creating a Buy signal.
FHTX Technical Analysis vs Fundamental Analysis
Sell
50
Foghorn Therapeutics (FHTX)
is a Sell
Is Foghorn Therapeutics a Buy or a Sell?
-
Foghorn Therapeutics stock is rated a Sell
The current Foghorn Therapeutics [FHTX] share price is $8.01. The Score for FHTX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Foghorn Therapeutics Stock Info
Market Cap:
445.3M
Price in USD:
8.01
Share Volume:
240.61K
Foghorn Therapeutics 52-Week Range
52-Week High:
10.25
52-Week Low:
2.70
Sell
50
Foghorn Therapeutics (FHTX)
is a Sell
Foghorn Therapeutics Share Price Forecast
-
What is the Foghorn Therapeutics stock price today?
The Foghorn Therapeutics stock price is 8.01 USD today. -
Will FHTX stock go up or go down?
Foghorn Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Foghorn Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Foghorn Therapeutics is overvalued.
Is Foghorn Therapeutics Stock a Buy?
- Foghorn Therapeutics share price is 8.01 while FHTX 8-day exponential moving average is 8.66, which is a Sell signal.
- The stock price of FHTX is 8.01 while Foghorn Therapeutics 20-day EMA is 8.50, which makes it a Sell.
- Foghorn Therapeutics 50-day exponential moving average is 8.20 while FHTX share price is 8.01, making it a Sell technically.
- FHTX stock price is 8.01 and Foghorn Therapeutics 200-day simple moving average is 7.08, creating a Buy signal.
Fundamental Analysis of Foghorn Therapeutics
Is Foghorn Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and an increase next year of $0.33 per share.
Technical Analysis of Foghorn Therapeutics
Should I short Foghorn Therapeutics stock?
- FHTX Moving Average Covergence Divergence (MACD) indicator is 0.18, suggesting Foghorn Therapeutics is a Buy
- Foghorn Therapeutics Relative Strength Index (RSI) is 44.69, which suggest Foghorn Therapeutics is oversold
- The Bollinger Bands (25) for Foghorn Therapeutics is (7.57 - 8.85), which suggest Foghorn Therapeutics is a Buy
- The Bollinger Bands (100) for Foghorn Therapeutics is (6.08 - 8.88), which suggest Foghorn Therapeutics is a Buy
* Foghorn Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.